PLRZ
Polyrizon Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$9.69
−3.15%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-22.4%
Return on equity
-22.0%
Return on assets
-52.2%
Return on invested capital
0.00x
Asset turnover
-$7.0M
Cash from operations
$6.20
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026